Cholesterol precursors: More than mere markers of biosynthesis

Current Opinion in Lipidology

Volumn 25, Issue 2, 2014, Pages 133-139

  Brown, Andrew J ^a   Ikonen, Elina ^b,c   Olkkonen, Vesa M ^c  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

^b UNIVERSITY OF HELSINKI   (Finland)

^c MINERVA FOUNDATION INSTITUTE FOR MEDICAL RESEARCH   (Finland)

Author keywords

Cholesterol precursors; Hepatitis B viruses; Hepatitis C viruses; Sterols; Vitamin D

Indexed keywords

7 DEHYDROCHOLESTEROL; BIOLOGICAL MARKER; DESMOSTEROL; DHCR24 ENZYME; DHCR7 ENZYME; ENZYME; SQUALENE; UNCLASSIFIED DRUG; VITAMIN D;

CARDIOVASCULAR RISK; CHOLESTEROL SYNTHESIS; CHRONIC LIVER DISEASE; DISEASE MARKER; HEPATITIS C VIRUS; HOST RESISTANCE; HUMAN; KUPFFER CELL; LIVER CELL; LIVER DISEASE; NONALCOHOLIC FATTY LIVER; PRIORITY JOURNAL; REVIEW; VIRUS REPLICATION; VIRUS VIRULENCE; VITAMIN BLOOD LEVEL;

HEPACIVIRUS; HEPATITIS B VIRUS; HEPATITIS C VIRUS;

ANIMALS; BIOLOGICAL MARKERS; CARDIOVASCULAR DISEASES; CHOLESTEROL; FATTY LIVER; HUMANS; SQUALENE;

EID: 84897029187     PISSN: 09579672     EISSN: 14736535     Source Type: Journal    
DOI: 10.1097/MOL.0000000000000038     Document Type: Review

References (44)

1. Miettinen TA. Serum squalene and methyl sterols as indicators of cholesterol synthesis in vivo. Life Sci 1969; 8:713-721.
2. Mackay DS, Jones PJ. Plasma noncholesterol sterols: Current uses, potential and need for standardization. Curr Opin Lipidol 2012; 23:241-247.
3. Miettinen TA, Gylling H, Nissinen MJ. The role of serum noncholesterol sterols as surrogate markers of absolute cholesterol synthesis and absorption. Nutr Metab Cardiovasc Dis 2011; 21:765-769.
4. Simonen M, Mannisto V, Leppanen J, et al. Desmosterol in human nonalcoholic steatohepatitis. Hepatology (Baltimore, Md) 2013; 58:976-982.
5. Sharpe LJ, Brown AJ. Controlling cholesterol synthesis beyond 3-hydroxy-3-methylglutaryl-CoA reductase (HMGCR). J Biol Chem 2013; 13:260-273.
6. Matthan NR, Zhu L, Pencina M, et al. Sex-specific differences in the predictive value of cholesterol homeostasis markers and 10-year cardiovascular disease event rate in framingham offspring study participants. J Am Heart Assoc 2013; 2:e005066.
7. Rajaratnam RA, Gylling H, Miettinen TA. Independent association of serum squalene and noncholesterol sterols with coronary artery disease in postmenopausal women. J Am Coll Cardiol 2000; 35:1185-1191.
8. Gill S, Stevenson J, Kristiana I, Brown AJ. Cholesterol-dependent degradation of squalene monooxygenase, a control point in cholesterol synthesis beyond HMG-CoA reductase. Cell Metab 2011; 13:260-273.
9. Li X, Xia M, Ma H, et al. Liver fat content is associated with increased carotid atherosclerosis in a Chinese middle-Aged and elderly population: The Shanghai Changfeng study. Atherosclerosis 2012; 224:480-485.
10. Brindisi MC, Guiu B, Duvillard L, et al. Liver fat content is associated with an increase in cholesterol synthesis independent of statin therapy use in patients with type 2 diabetes. Atherosclerosis 2012; 224:465-468.
11. Ikegami T, Hyogo H, Honda A, et al. Increased serum liver X receptor ligand oxysterols in patients with nonalcoholic fatty liver disease. J Gastroenterol 2012; 47:1257-1266.
12. Ioannou GN, Haigh WG, Thorning D, Savard C. Hepatic cholesterol crystals and crown-like structures distinguish NASH from simple steatosis. J Lipid Res 2013; 54:1326-1334.
13. Min HK, Kapoor A, Fuchs M, et al. Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease. Cell Metab 2012; 15:665-674.
14. Tosello-Trampont AC, Landes SG, Nguyen V, et al. Kuppfer cells trigger nonalcoholic steatohepatitis development in diet-induced mouse model through tumor necrosis factor-Alpha production. J Biol Chem 2012; 287:40161-40172.
15. Spann N, Garmire L, McDonald J, et al. Regulated accumulation of desmosterol integrates macrophage lipid metabolism and inflammatory responses. Cell 2012; 151:138-152.
16. Lima-Cabello E, Garcia-Mediavilla MV, Miquilena-Colina ME, et al. Enhanced expression of pro-inflammatory mediators and liver X-receptor-regulated lipogenic genes in nonalcoholic fatty liver disease and hepatitis C. Clin Sci (London, England: 1979) 2011; 120:239-250.
17. Zerenturk EJ, Sharpe LJ, Brown AJ. Sterols regulate 3beta-hydroxysterol Delta24-reductase (DHCR24) via dual sterol regulatory elements: Cooperative induction of key enzymes in lipid synthesis by Sterol Regulatory Element Binding Proteins. Biochim Biophys Acta 2012; 1821:1350-1360.
18. Zerenturk EJ, Kristiana I, Gill S, Brown AJ. The endogenous regulator 24(S),25-epoxycholesterol inhibits cholesterol synthesis at DHCR24 (Seladin-1). Biochim Biophys Acta 2012; 1821:1269-1277.
19. Jansen M, Wang W, Greco D, et al. What dictates the accumulation of desmosterol in the developing braiñ FASEB J 2013; 27:865-870.
20. Brown AJ. Viral hepatitis and fatty liver disease: How an unwelcome guest makes pate of the host. Biochem J 2008; 416:e15-e17.
21. Rodgers MA, Villareal VA, Schaefer EA, et al. Lipid metabolite profiling identifies desmosterol metabolism as a new antiviral target for hepatitis C virus. J Am Chem Soc 2012; 134:6896-6899.
22. Garcia-Mediavilla MV, Pisonero-Vaquero S, Lima-Cabello E, et al. Liver X receptor alpha-mediated regulation of lipogenesis by core and NS5A proteins contributes to HCV-induced liver steatosis and HCV replication. Lab Invest 2012; 92:1191-1202.
23. Zeng J,WuY, Liao Q, et al. Liver X receptors agonists impede hepatitisCvirus infection in an Idol-dependent manner. Antiviral Res 2012; 95:245-256.
24. Sorrentino V, Zelcer N. Posttranscriptional regulation of lipoprotein receptors by the E3-ubiquitin ligase inducible degrader of the low-density lipoprotein receptor. Curr Opin Lipidol 2012; 23:213-219.
25. Rodgers MA, Saghatelian A, Yang PL. Identification of an overabundant cholesterol precursor in hepatitis B virus replicating cells by untargeted lipid metabolite profiling. J Am Chem Soc 2009; 131:5030-5031.
26. Nowaczyk MJ, Irons MB. Smith-Lemli-Opitz syndrome: Phenotype, natural history, and epidemiology. Am J Med Genet C Semin Med Genet 2012; 160C:250-262.
27. Porter FD, Herman GE. Malformation syndromes caused by disorders of cholesterol synthesis. J Lipid Res 2011; 52:6-34.
28. Kitson MT, Roberts SK. D-livering the message: The importance of vitamin D status in chronic liver disease. J Hepatol 2012; 57:897-909.
29. Wang TJ, Zhang F, Richards JB, et al. Common genetic determinants of vitamin D insufficiency: A genome-wide association study. Lancet 2010; 376:180-188.
30. Lange CM, Miki D, Ochi H, et al. Genetic analyses reveal a role for vitamin D insufficiency in HCV-Associated hepatocellular carcinoma development. PLoS One 2013; 8:e64053.
31. Petta S, Grimaudo S, Marco VD, et al. Association of vitamin D serum levels and its common genetic determinants, with severity of liver fibrosis in genotype 1 chronic hepatitis C patients. J Viral Hepat 2013; 20:486-493.
32. Grunhage F, Hochrath K, Krawczyk M, et al. Common genetic variation in vitamin D metabolism is associated with liver stiffness. Hepatology (Baltimore, Md) 2012; 56:1883-1891.
33. Weingärtner O, Lütjohann D, Vanmierlo T, et al. Markers of enhanced cholesterol absorption are a strong predictor for cardiovascular diseases in patients without diabetes mellitus. Chem Phys Lipids 2011; 164:451-456.
34. Kolsch H, Heun R, Jessen F, et al. Alterations of cholesterol precursor levels in Alzheimer's disease. Biochim Biophys Acta 2010; 1801:945-950.
35. Hoenig MR, Sellke FW. Insulin resistance is associated with increased cholesterol synthesis, decreased cholesterol absorption and enhanced lipid response to statin therapy. Atherosclerosis 2010; 211:260-265.
36. Nunes VS, Leanca CC, Panzoldo NB, et al. HDL-C concentration is related to markers of absorption and of cholesterol synthesis: Study in subjects with low vs. high HDL-C. Clin Chim Acta 2011; 412:176-180.
37. Gylling H, Hallikainen M, Kolehmainen M, et al. Cholesterol synthesis prevails over absorption in metabolic syndrome. Transl Res 2007; 149:310-316.
38. Miettinen TA, Hallikainen M, Raitakari OT, et al. Twenty-one year tracking of serum noncholesterol sterols. The Cardiovascular Risk in Young Finns study. Nutr Metab Cardiovasc Dis 2009; 19:525-531.
39. Peri A, Danza G, Benvenuti S, et al. New insights on the neuroprotective role of sterols and sex steroids: The seladin-1/DHCR24 paradigm. Front Neuroendocrinol 2009; 30:119-129.
40. Zu H, Wu J, Zhang J, et al. Testosterone up-regulates seladin-1 expression by iAR and PI3-K/Akt signaling pathway in C6 cells. Neurosci Lett 2012; 514:122-126.
41. Gylling H, Hallikainen M, Pihlajamaki J, et al. Insulin sensitivity regulates cholesterol metabolism to a greater extent than obesity: Lessons from the METSIM Study. J Lipid Res 2010; 51:2422-2427.
42. Nissinen MJ, Miettinen TE, Gylling H, Miettinen TA. Applicability of noncholesterol sterols in predicting response in cholesterol metabolism to simvastatin and fluvastatin treatment among hypercholesterolemic men. Nutr Metab Cardiovasc Dis 2010; 20:308-316.
43. Matysik S, Klunemann HH, Schmitz G. Gas chromatography-Tandem mass spectrometry method for the simultaneous determination of oxysterols, plant sterols, and cholesterol precursors. Clin Chem 2012; 58:1557-1564.
44. McDonald JG, Smith DD, Stiles AR, Russell DW. A comprehensive method for extraction and quantitative analysis of sterols and secosteroids from human plasma. J Lipid Res 2012; 53:1399-1409.